We previously reported that subcutaneous or intraperitoneal transplantation of ovarian cancer cells overexpressing VASH1 retarded tumor growth and peritoneal dissemination by inhibiting tumor angiogenesis, thereby prolonging host survival in murine xenograft models [8]. This evidence concerns the gene VASH1 and ovarian carcinoma.